UBS analyst Mate Nemes maintained a Buy rating on Deutsche Bank AG (DB – Research Report) today and set a price target of €20.00. The company’s

UBS analyst Michael Werner maintained a Hold rating on DWS Group GmbH & Co KGaA (DWS – Research Report) today and set a price target of

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.51% of Western Alliance Bancorporation (WAL)’s shares, while financial institutions hold 89.88%.

Deutsche Bank is scheduled to report results for the fourth quarter of 2024 on Thursday, Jan. 30. It is also expected to announce a share buyback after last year's pause following a court decision on a legal case stemming from the acquisition of former rival Postbank more than a decade ago. Here is what you need to know:

Synovus Financial Corp (SNV) stock saw a modest uptick, ending the day at $55.17 which represents a slight increase of $0.04 or 0.07% from the prior close of $55.13. The stock opened at $55.19 and touched a low of $54.

William “Bill” Bruen Jr. and his son Andrew join an existing LPL practice after spending more than a decade at UBS. We recently compiled a list of the 10 Best European Bank Stocks to Buy ...

A group of senior financial industry professionals has launched Jackson Square Partners, a capital advisory boutique based in London and New York. The new firm said it will focus on private equity-sponsored businesses and corporates in the middle market, and developers and operators of real estate and infrastructure projects.

M Co (MMM) stock saw a modest uptick, ending the day at $139.18 which represents a slight increase of $1.40 or 1.02% from the prior close of $137.78. The stock opened at $138.03 and touched a low of $136.

UBS analyst Joseph Spak increased the price target for Dana Holding (NYSE:DAN) shares to $20.00, up from the previous $18.00, while keeping a Buy rating on the stock. The adjustment follows Dana's recent business update,

In a report released today, Jo Walton from UBS maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price target of